Analyst Price Targets — MLAB
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 14, 2026 12:03 pm | Brandon Couillard | Wells Fargo | $110.00 | $111.64 | TheFly | Mesa Labs price target raised to $110 from $94 at Wells Fargo |
| February 4, 2026 11:32 am | — | Wells Fargo | $94.00 | $87.53 | TheFly | Mesa Labs price target raised to $94 from $83 at Wells Fargo |
| December 15, 2025 11:28 am | — | Wells Fargo | $83.00 | $77.76 | TheFly | Mesa Labs price target raised to $83 from $75 at Wells Fargo |
| August 27, 2024 4:19 pm | Brandon Couillard | Wells Fargo | $120.00 | $140.86 | TheFly | Mesa Labs initiated with an Underweight at Wells Fargo |
| June 7, 2024 8:15 am | Vijay Kumar | Evercore ISI | $120.00 | $104.80 | StreetInsider | Evercore ISI Removes Mesa Laboratories (MLAB) from TAP List |
Latest News for MLAB
Mesa Laboratories (NASDAQ: MLAB - Get Free Report) and ImmunoPrecise Antibodies (OTCMKTS:IPATF - Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, valuation, risk and analyst recommendations. Earnings and Valuation This table compares Mesa Laboratories
Mesa Laboratories, Inc. (MLAB) Q1 2027 Earnings Call Transcript
Mesa Laboratories NASDAQ: MLAB reported first-quarter fiscal 2027 revenue growth of 1%, improved operating margins and continued debt reduction, while newly appointed President and CEO Siddhartha Kadia outlined plans to address fulfillment issues in its Sterilization and Disinfection Control business and accelerate product development in Biopharmaceutical Development.
LAKEWOOD, Colo., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced it will release financial results for its first fiscal quarter (“1Q27”) ended June 30, 2026 following market close on Monday, August 10, 2026. The Company will also…
Lakewood, Colo., July 06, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September 15, 2026, to shareholders of record at the close of business on August 31, 2026.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for MLAB.
U.S. House Trading
No House trades found for MLAB.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.